Inside Penn

In brief, what’s happening at Penn—whether it’s across campus or around the world.

Filter Stories

Displaying 371 - 380 of 924
  • Prioritizing vulnerable communities in COVID-19 vaccinations and boosters

    As the nation continues to grapple with outbreaks of COVID-19, the Biden Administration released a statement that concludes a booster shot will be needed to maximize vaccine-induced protection. Penn LDI’s Nadiyah Browning and Janet Weiner examine how these boosters and attendant resources be allocated so that communities that are most vulnerable and disadvantaged are prioritized.

    FULL STORY AT Leonard Davis Institute

  • CRISPR screening tool identifies new drug target for leukemia

    A CRISPR screening tool identified a new therapeutic target to treat acute myeloid leukemia (AML) that has the potential to leave patients with fewer side effects than current approaches, according to a new study from Penn Medicine published in Molecular Cell.

    FULL STORY AT Penn Medicine News

  • Existing drug may help improve responses to cellular therapies in advanced leukemias

    A new Penn Medicine study identifies a new mechanism of resistance and how to overcome it with a small molecule inhibitor.

    FULL STORY AT Penn Medicine News

  • Penn Dental Medicine student research in spotlight on international stage

    Over 30 student researchers were included in the scientific program with their faculty mentors, showcasing a diversity of projects across disciplines.

    FULL STORY AT Penn Dental Medicine

  • Penn Dental Medicine faculty, fellow earn top research awards

    Penn Dental Medicine faculty member Yuan Liu and postdoctoral fellow Zhi Ren have been recognized for their excellence in research, recently receiving top awards from the American Association for Dental, Oral, and Craniofacial Research (AADOCR) and the International Association for Dental Research (IADR).

    FULL STORY AT Penn Dental Medicine

  • Penn study finds new possible cell target to treat clear cell renal cell carcinoma

    The scientists found the health of these specific cancer cells and tumors are dependent upon cholesterol and this receptor, while also showing that medication that specifically targets the receptor could make it impossible for the cancer cells to survive and spread.

    FULL STORY AT Penn Medicine News

  • Penn’s Perelman School of Medicine establishes Roberts Family Professorship and Fellowship for vaccine research and development

    The endowed chair and fellowship funds were created through a gift from the Aileen and Brian Roberts Foundation, underscoring the Roberts family’s strong support of Penn Medicine and their passion for cutting-edge healthcare.

    FULL STORY AT Penn Medicine News

  • Assistive technology for infants with cleft palate wins inaugural Advancing Oral & Craniofacial Health Award

    The Center for Innovation and Precision Dentistry,a collaboration between Penn Dental Medicine and Penn Engineering, has presented its inaugural Advancing Oral & Craniofacial Health Award to Eugene Ko, assistant professor of clinical oral medicine at Penn Dental Medicine, who will be collaborating with Shu Yang, chair and Joseph Bordogna Professor in the Department of Materials Science and Engineering, with a secondary appointment in the Department Chemical and Biomolecular Engineering.

    FULL STORY AT Penn Engineering Today

  • Penn Medicine launching center for applied health informatics

    In a move that will enhance Penn Medicine’s clinical, operational, and research and clinical capabilities, the health system is launching the Center for Applied Health Informatics to better facilitate and coordinate health data projects across the health system and grow its leadership in health informatics globally.

    FULL STORY AT Penn Medicine News

  • Penn Medicine-led research team awarded $2.9 million to study heart disease and cancer in Black and Hispanic communities

    The grant awarded to the Cardio-Oncology Translational Center of Excellence at Penn Medicine will fund projects aimed at reducing racial disparities in breast and prostate cancer patients with a higher risk for cardiovascular disease.

    FULL STORY AT Penn Medicine News